These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28757416)

  • 1. The tumour suppressor, miR-137, inhibits malignant melanoma migration by targetting the TBX3 transcription factor.
    Peres J; Kwesi-Maliepaard EM; Rambow F; Larue L; Prince S
    Cancer Lett; 2017 Oct; 405():111-119. PubMed ID: 28757416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The T-box transcription factor, TBX3, is a key substrate of AKT3 in melanomagenesis.
    Peres J; Mowla S; Prince S
    Oncotarget; 2015 Jan; 6(3):1821-33. PubMed ID: 25595898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF.
    Peres J; Damerell V; Chauhan J; Popovic A; Desprez PY; Galibert MD; Goding CR; Prince S
    J Invest Dermatol; 2021 Sep; 141(9):2250-2260.e2. PubMed ID: 33744299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer.
    Amir S; Simion C; Umeh-Garcia M; Krig S; Moss T; Carraway KL; Sweeney C
    Br J Cancer; 2016 May; 114(10):1125-34. PubMed ID: 27100732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
    Mueller DW; Bosserhoff AK
    Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
    Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
    Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy.
    Mishra PJ; Mishra PJ; Merlino G
    PLoS One; 2016; 11(11):e0165102. PubMed ID: 27846237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.
    Luo C; Tetteh PW; Merz PR; Dickes E; Abukiwan A; Hotz-Wagenblatt A; Holland-Cunz S; Sinnberg T; Schittek B; Schadendorf D; Diederichs S; Eichmüller SB
    J Invest Dermatol; 2013 Mar; 133(3):768-775. PubMed ID: 23151846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
    Su BB; Zhou SW; Gan CB; Zhang XN
    J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of FLOT2 as a novel target for microRNA-34a in melanoma.
    Liu R; Xie H; Luo C; Chen Z; Zhou X; Xia K; Chen X; Zhou M; Cao P; Cao K; Zhou J
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):993-1006. PubMed ID: 25403318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MLK3 promotes melanoma proliferation and invasion and is a target of microRNA-125b.
    Zhang J; Lu L; Xiong Y; Qin W; Zhang Y; Qian Y; Jiang H; Liu W
    Clin Exp Dermatol; 2014 Apr; 39(3):376-84. PubMed ID: 24635082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.
    Rodriguez M; Aladowicz E; Lanfrancone L; Goding CR
    Cancer Res; 2008 Oct; 68(19):7872-81. PubMed ID: 18829543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion.
    Boyd SC; Mijatov B; Pupo GM; Tran SL; Gowrishankar K; Shaw HM; Goding CR; Scolyer RA; Mann GJ; Kefford RF; Rizos H; Becker TM
    J Invest Dermatol; 2013 May; 133(5):1269-77. PubMed ID: 23190890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-216b inhibits cell proliferation and migration in human melanoma by targeting FOXM1 in vitro and in vivo.
    Sun M; Wang X; Tu C; Wang S; Qu J; Xiao S
    Cell Biol Int; 2017 Dec; 41(12):1272-1282. PubMed ID: 28225180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COL1A2 is a TBX3 target that mediates its impact on fibrosarcoma and chondrosarcoma cell migration.
    Omar R; Cooper A; Maranyane HM; Zerbini L; Prince S
    Cancer Lett; 2019 Sep; 459():227-239. PubMed ID: 31202624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
    Bai J; Zhang Z; Li X; Liu H
    Int J Clin Exp Pathol; 2015; 8(5):4913-22. PubMed ID: 26191184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma.
    Bhattacharya A; Schmitz U; Wolkenhauer O; Schönherr M; Raatz Y; Kunz M
    Oncogene; 2013 Jun; 32(26):3175-83. PubMed ID: 22847610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD).
    Reuland SN; Smith SM; Bemis LT; Goldstein NB; Almeida AR; Partyka KA; Marquez VE; Zhang Q; Norris DA; Shellman YG
    J Invest Dermatol; 2013 May; 133(5):1286-93. PubMed ID: 23190898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D.
    Heinemann A; Zhao F; Pechlivanis S; Eberle J; Steinle A; Diederichs S; Schadendorf D; Paschen A
    Cancer Res; 2012 Jan; 72(2):460-71. PubMed ID: 22102694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
    Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
    BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.